Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch

NCT03943407 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The Imiquimod 3.75% was ineffective

Conditions

Itch

Interventions

DRUG: Zyclara 3.75 % Topical Cream
DRUG: Prudoxin
OTHER: Histamine
OTHER: Cowhage
OTHER: L-menthol
OTHER: Trans-cinnamaldehyde (CA)

Sponsor

Aalborg University